Search results for "VARY"

showing 10 items of 682 documents

Long-term consequences of polycystic ovary syndrome on cardiovascular risk

2009

Most available data suggest that the prevalence of cardiovascular diseases in women with polycystic ovary syndrome (PCOS) is smaller than expected based on risk calculations during fertile years; therefore, more studies are needed on long-term cardiovascular consequences. Evidence is accumulating that postmenopausal women with PCOS have an increased risk of cerebrovascular events and cardiovascular morbidity. These events are partially related to persisting hyperandrogenism but are mostly correlated with excessive body weight (mainly visceral obesity); this suggests that our best long-term strategy is to ensure that women with PCOS are informed about their high risk for metabolic and cardio…

AdultPolycystic ovary syndrome cardiovascular risk menopause eventsAgingPediatricsmedicine.medical_specialty10265 Clinic for Endocrinology and Diabetology610 Medicine & healthBody weightDiabetes ComplicationsRisk FactorsmedicineHumansCystObesityAgedAged 80 and overGynecologyPostmenopausal womenbusiness.industryHyperandrogenismObstetrics and Gynecology2729 Obstetrics and Gynecology2743 Reproductive MedicineMiddle Agedmedicine.diseasePolycystic ovaryMenopauseC-Reactive ProteinIncreased riskReproductive MedicineCardiovascular DiseasesAndrogensFemaleAdiponectinHyperandrogenismbusinessBiomarkersVisceral ObesityPolycystic Ovary Syndrome
researchProduct

High progesterone levels in women with high ovarian response do not affect clinical outcomes: a retrospective cohort study

2014

Background The potentially detrimental role of progesterone during the follicular phase has been a matter of controversy for several years; however, few studies have analyzed the effects of combined raised estradiol and progesterone levels on pregnancy outcomes. The aim of the present study was to determine the influence of high progesterone levels on clinical outcomes in the context of high ovarian response. Methods We performed a retrospective cohort study that included 2850 women classified as high responders. The women were subdivided into six groups depending on their progesterone concentration on the day of human chorionic gonadotropin (hCG) administration: 1.81 ng/ml (>p90). Ovarian …

AdultPregnancy Ratemedicine.medical_treatmentContext (language use)Fertilization in VitroBiologyChorionic GonadotropinHuman chorionic gonadotropinCohort StudiesAndrologyYoung AdultOogenesisEndocrinologyOvulation InductionPregnancyHigh progesteroneClinical outcomesFollicular phasemedicineHumansChorionic Gonadotropin beta Subunit HumanSperm Injections IntracytoplasmicProgesteroneRetrospective StudiesPregnancyEstradiolResearchOvaryObstetrics and GynecologyRetrospective cohort studyFertility Agents Femalemedicine.diseaseUp-RegulationPregnancy rateFollicular PhaseROC CurveReproductive MedicineSpainHigh respondersFemaleOvulation inductionOvarian responseInfertility FemaleCohort studyDevelopmental BiologyReproductive Biology and Endocrinology
researchProduct

Ovarian Endometrioid-like Yolk Sac Tumor Treated by Surgery Alone, with Recurrence at 12 Years

1999

Abstract We describe the case of a stage Ia endometrioid-like yolk sac tumor (YST) of the ovary, which was originally misdiagnosed as a malignant struma ovarii and not treated with adjuvant chemotherapy. After 12 years, a contralateral dermoid cyst was excised along with a small omental nodule of partially necrotic and calcified endometrioid-like YST. No tumor was detected in several other biopsy specimens, and a peritoneal lavage was negative for tumor cells. Since there was no evidence of remaining tumor and the serum α-fetoprotein (AFP) level was normal after the second operation, the patient was followed. Serial serum AFP levels remained normal for 4 months. At a second-look laparotomy …

AdultReoperationPathologymedicine.medical_specialtyTime Factorsmedicine.medical_treatmentOvaryLaparotomyBiopsyHumansMedicineYolk sacPeritoneal NeoplasmsOvarian Neoplasmsmedicine.diagnostic_testbusiness.industryEndodermal Sinus TumorObstetrics and GynecologyMalignant Struma Ovariimedicine.diseaseSurgerymedicine.anatomical_structureOncologyDermoid cystFemaleHistopathologyNeoplasm Recurrence LocalPouchbusinessOmentumGynecologic Oncology
researchProduct

Evaluation of Xerostomia and salivary flow rate in Hashimoto’s Thyroiditis

2015

Background: One of the most common causes of hypothyroidism is Hashimoto´s Thyroiditis (HT). Early detection of dry mouth is critical in preserving and promoting systemic and oral health. In this study we have assessed, for the first time, salivary function and xerostomia in HT patients who have not been involved with Sjögren´s syndrome. Material and Methods: HT was diagnosed in 40 patients based on clinical findings and positive anti-thyroid peroxidase antibodies (anti-TPO). Controls, matched by sex, age and body mass index (BMI), and with no history of thyroid disease, were selected. A questionnaire was used for diagnosis of xerostomia. Saliva samples were taken between 8 a.m. and 9 a.m.,…

AdultSalivamedicine.medical_specialtyOdontologíaHashimoto DiseaseGastroenterologyXerostomiaThyroiditis03 medical and health sciences0302 clinical medicinestomatognathic systemInternal medicineMedicineHumansHashimoto DiseaseGeneral Dentistry030203 arthritis & rheumatologyOral Medicine and PathologySalivary glandbusiness.industryThyroid diseaseResearchThyroid030206 dentistry:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseDry mouthCiencias de la saludstomatognathic diseasesEndocrinologymedicine.anatomical_structureCross-Sectional StudiesOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASSurgeryFemalemedicine.symptombusinessSalivationBody mass indexMedicina Oral, Patología Oral y Cirugía Bucal
researchProduct

PCOS: metabolic impact and long-term management.

2012

Polycystic ovary syndrome (PCOS) is the most frequent endocrinopathy in women, affecting up to 10% of those in reproductive age. Furthermore, PCOS presents a lifetime risk of type II diabetes, cardiovascular diseases and endometrial cancer. Women with PCOS have increased cardiovascular risk; however, the risk is not the same in all patients and it is necessary to assess an individual risk profile. There is a discrepancy between increased cardiovascular risk at young age and postmenopausal number of cardiovascular events, probablu depending on changes in androgen ovarian function after the forties. However, changes with age of metabolic profile in women with PCOS have not been studied yet an…

AdultSettore MED/09 - Medicina InternaAdolescentComorbiditySettore MED/11 - Malattie Dell'Apparato CardiovascolareMetforminSettore MED/13 - EndocrinologiaDiabetes Mellitus Type 2Cardiovascular DiseasesRisk FactorsObesity AbdominalPCOS Metabolic Syndrome Cardiovascular risk aging insulin resistance hyperandrogenismHypertensionHumansFemaleHydroxymethylglutaryl-CoA Reductase InhibitorsInsulin ResistanceChildAntihypertensive AgentsDyslipidemiasPolycystic Ovary SyndromeMinerva ginecologica
researchProduct

Time-Varying Surrogate Data to Assess Nonlinearity in Nonstationary Time Series: Application to Heart Rate Variability

2009

We propose a method to extend to time-varying (TV) systems the procedure for generating typical surrogate time series, in order to test the presence of nonlinear dynamics in potentially nonstationary signals. The method is based on fitting a TV autoregressive (AR) model to the original series and then regressing the model coefficients with random replacements of the model residuals to generate TV AR surrogate series. The proposed surrogate series were used in combination with a TV sample entropy (SE) discriminating statistic to assess nonlinearity in both simulated and experimental time series, in comparison with traditional time-invariant (TIV) surrogates combined with the TIV SE discrimin…

AdultTime FactorsComputer scienceRestBiomedical EngineeringSurrogate dataHeart RateStatisticsHumansHeart rate variabilityEntropy (information theory)Computer SimulationNonstationarityEntropy (energy dispersal)Time seriesEntropy (arrow of time)StatisticModels StatisticalEntropy (statistical thermodynamics)RespirationNonlinear dynamicModels CardiovascularComplexitySample entropyNonlinear systemNonlinear DynamicsAutoregressive modelSettore ING-INF/06 - Bioingegneria Elettronica E InformaticaSurrogate dataTime-varying (TV) autoregressive (AR) modelHeart rate variability (HRV)AlgorithmsEntropy (order and disorder)IEEE Transactions on Biomedical Engineering
researchProduct

Improving ovarian tissue cryopreservation for oncologic patients: slow freezing versus vitrification, effect of different procedures and devices.

2013

Objective To compare slow freezing (SF) with four vitrification techniques (VT) for cryopreservation of ovarian tissue (OT) and to evaluate the best protocol for human OT in a xenograft model. Design Experimental study. Setting University hospital. Patient(s) Patients undergoing fertility preservation. Animal(s) Ovariectomized nude mice. Intervention(s) Cryopreservation of bovine OT after SF and four VTs (VT1, VT2, VT3, and VT4) by combining two cryoprotectant vitrification solutions (VS1 and VS2) and two devices (metallic grid and ethyl vinyl acetate bag), after which the cryopreservation of human OT by SF and VT1 and xenograft into nude mice. Main Outcome Measure(s) Follicular densities, …

AdultTime FactorsCryoprotectantAdolescentPopulationMice NudeBreast NeoplasmsBiologyCryopreservationAndrologyMiceRandom AllocationYoung AdultFresh TissueFollicular phaseAnimalsHumansVitrificationOvarian tissue cryopreservationeducationCell ProliferationCryopreservationeducation.field_of_studyOvaryObstetrics and GynecologyFertility PreservationHodgkin DiseaseVitrificationXenograft Model Antitumor AssaysTransplantationTreatment OutcomeReproductive MedicineImmunologyCattleFemaleFertility and sterility
researchProduct

Dopamine receptor 2 activation inhibits ovarian vascular endothelial growth factor secretion in vitro: implications for treatment of ovarian hypersti…

2013

Objective To ascertain whether vascular endothelial growth factor (VEGF) secretion by luteinized granulosa cells (GCs) is modulated by the dopaminergic system in a dose-dependent fashion and how this is related to the differential efficacy of dopamine receptor 2 (D2)-agonists (D2-ag) in preventing ovarian hyperstimulation syndrome (OHSS). Design The relationship between the dopaminergic system and VEGF secretion in luteinized GCs was evaluated. Archived human ovaries were immunostained to characterize D2 expression. Setting University affiliated infertility center. Patient(s) Premenopausal women and egg donors. Intervention(s) Luteinized GCs were cultured with the D2-ag cabergoline. Human o…

AdultVascular Endothelial Growth Factor Aendocrine systemmedicine.medical_specialtyOvarian hyperstimulation syndromePilot ProjectsLuteal phaseBiologyOvarian Hyperstimulation Syndromechemistry.chemical_compoundCabergolineInternal medicinemedicineHumansSecretionCells CulturedGranulosa CellsReceptors Dopamine D2OvaryDopaminergicObstetrics and GynecologyMiddle Agedmedicine.diseaseVascular endothelial growth factorTreatment OutcomeEndocrinologyReproductive MedicinechemistryDopamine receptorDopamine AgonistsImmunohistochemistryFemalesense organsmedicine.drugFertility and Sterility
researchProduct

Influence of obesity on atherogenic dyslipidemia in women with polycystic ovary syndrome.

2013

Background Obesity is known to underlie, at least partially, dyslipidemia in polycystic ovary syndrome (PCOS), but it is unclear whether PCOS status per se increases the risk of alterations of lipoprotein subfractions, which differ in size and atherogenic potential. Our objective was to evaluate whether PCOS influences lipoprotein profile and LDL and HDL subfractions and to study the impact of obesity on these parameters. Materials and methods This was a case–control study conducted in an academic medical centre. The study population consisted of 54 women of fertile age with PCOS and 60 controls adjusted for age and BMI. Biochemical lipid profile and LDL and HDL lipoprotein subfractions (me…

AdultVery low-density lipoproteinmedicine.medical_specialtyendocrine system diseasesClinical BiochemistryBiochemistryBody Mass Indexchemistry.chemical_compoundRisk FactorsInternal medicinemedicineHumansObesityDyslipidemiasmedicine.diagnostic_testCholesterolbusiness.industryCholesterol HDLCase-control studynutritional and metabolic diseasesCholesterol LDLGeneral MedicineAtherosclerosismedicine.diseasePolycystic ovaryfemale genital diseases and pregnancy complicationsEndocrinologychemistryCase-Control StudiesFemalelipids (amino acids peptides and proteins)Lipid profilebusinessBody mass indexDyslipidemiaPolycystic Ovary SyndromeLipoprotein
researchProduct

A 20-year follow-up of young women with polycystic ovary syndrome.

2012

OBJECTIVE: To determine whether hormonal, metabolic, and anthropomorphic parameters change over 20 years in women with polycystic ovary syndrome (PCOS). METHODS: One hundred ninety-three women with PCOS, aged 20–25 years, were diagnosed according to Rotterdam criteria, divided into four phenotypes (A–D), and followed at 5-year intervals for 20 years. Androgens, gonadotropins, insulin, glucose, body mass index, waist circumference, and ovarian volume were measured. RESULTS: At diagnosis, 57% had classic features (phenotype A), 9% had classic features without ovarian findings (phenotype B), 26% had the ovulatory phenotype (C), and 7% were nonhyperandrogenic (D). After 10 years, androgens decr…

Adultendocrine system diseasesPhysiologySettore MED/13 - EndocrinologiaBody Mass IndexYoung AdultInsulin resistanceOvarian functionmedicineHumansInsulinTestosteroneYoung adultInsulin bloodbusiness.industryOvaryFollow up studiesObstetrics and GynecologyDehydroepiandrosteroneOrgan SizeLuteinizing HormoneMiddle Agedmedicine.diseasePolycystic ovaryfemale genital diseases and pregnancy complicationsPolycystic Ovary Syndrome Ovarian function Ovarian aging Androgens Insulin resistance waist circumferencePhenotypeFemaleFollicle Stimulating HormoneInsulin ResistanceWaist CircumferencebusinessBody mass indexHormoneAnovulationFollow-Up StudiesPolycystic Ovary SyndromeObstetrics and gynecology
researchProduct